CLOSE ×

    Oncology

    Boven, E., Schipper, H., Erkelens, C. A., Hatty, S. A., & Pinedo, H. M. (1993)., The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer., British Journal of Cancer, 68(1), 52-56.
    Frandsen, S. K., Gissel, H., Hojman, P., Tramm, T., Eriksen, J., & Gehl, J. (2012)., Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis., Cancer Research, 72(6), 1336-1341. doi:10.1158/0008-5472.CAN-11-3782 [doi]
    Garcia-Garcia, C., Ibrahim, Y. H., Serra, V., Calvo, M. T., Guzman, M., Grueso, J., . . . Scaltriti, M. (2012)., Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 18(9), 2603-2612. doi:10.1158/1078-0432.CCR-11-2750 [doi]
    Hantel, C., Jung, S., Mussack, T., Reincke, M., & Beuschlein, F. (2014)., Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model., Endocrine-Related Cancer, 21(3), 383-394. doi:10.1530/ERC-13-0439 [doi]
    Hantel, C., Lewrick, F., Reincke, M., Suss, R., & Beuschlein, F. (2012)., Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma., The Journal of Endocrinology, 213(2), 155-161. doi:10.1530/JOE-11-0427 [doi]
    Ibrahim, Y. H., Garcia-Garcia, C., Serra, V., He, L., Torres-Lockhart, K., Prat, A., . . . Baselga, J. (2012)., PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition., Cancer Discovery, 2(11), 1036-1047. doi:10.1158/2159-8290.CD-11-0348 [doi]
    Kemmerling, R., Alinger, B., Dietze, O., Bosmuller, H. C., Ocker, M., Wolkersdorfer, G. W., . . . Kiesslich, T. (2012)., Association of stem cell marker expression pattern and survival in human biliary tract cancer., International Journal of Oncology, 41(2), 511-522. doi:10.3892/ijo.2012.1477 [doi]
    Knauer, S. K., Unruhe, B., Karczewski, S., Hecht, R., Fetz, V., Bier, C., . . . Stauber, R. H. (2013)., Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients., Human Mutation, 34(2), 395-404. doi:10.1002/humu.22249 [doi]
    Pool, S. E., Bison, S., Koelewijn, S. J., van der Graaf, L. M., Melis, M., Krenning, E. P., & de Jong, M. (2013)., mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer., Cancer Research, 73(1), 12-18. doi:10.1158/0008-5472.CAN-11-2089 [doi]
    Serra, V., Eichhorn, P. J., Garcia-Garcia, C., Ibrahim, Y. H., Prudkin, L., Sanchez, G., . . . Baselga, J. (2013)., RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer., The Journal of Clinical Investigation, 123(6), 2551-2563. doi:10.1172/JCI66343 [doi]
    Tritten, L., Nwosu, U., Vargas, M., & Keiser, J. (2012)., In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms heligmosomoides bakeri and ancylostoma ceylanicum., Acta Tropica, 122(1), 101-107. doi:10.1016/j.actatropica.2011.12.008 [doi]
    Wang, C. F., Sarparanta, M. P., Makila, E. M., Hyvonen, M. L., Laakkonen, P. M., Salonen, J. J., . . . Santos, H. A. (2015)., Multifunctional porous silicon nanoparticles for cancer theranostics., Biomaterials, 48, 108-118. doi:10.1016/j.biomaterials.2015.01.008 [doi]

    Tumor Growth

    Berenguer-Daize, C., Boudouresque, F., Bastide, C., Tounsi, A., Benyahia, Z., Acunzo, J., . . . Ouafik, L. (2013)., Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice., Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 19(22), 6138-6150. doi:10.1158/1078-0432.CCR-13-0691 [doi]
    Garcia-Alvarez, I., Garrido, L., Romero-Ramirez, L., Nieto-Sampedro, M., Fernandez-Mayoralas, A., & Campos-Olivas, R. (2013)., The effect of antitumor glycosides on glioma cells and tissues as studied by proton HR-MAS NMR spectroscopy., PloS One, 8(10), e78391. doi:10.1371/journal.pone.0078391 [doi]
    Geissler, C., Hambek, M., Eckardt, A., Arnoldner, C., Diensthuber, M., Stover, T., & Wagenblast, J. (2012)., The role of recombinant epidermal growth factor and serotonin in the stimulation of tumor growth in a SCCHN xenograft model., Oncology Reports, 28(3), 785-790. doi:10.3892/or.2012.1903 [doi]
    Geissler, C., Hambek, M., Leinung, M., Diensthuber, M., Gassner, D., Stover, T., & Wagenblast, J. (2012)., The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model., In Vivo (Athens, Greece), 26(4), 593-598. doi:26/4/593 [pii]
    Muellner, M. K., Mair, B., Ibrahim, Y., Kerzendorfer, C., Lechtermann, H., Trefzer, C., . . . Nijman, S. M. (2015)., Targeting a cell state common to triple-negative breast cancers., Molecular Systems Biology, 11(1), 789. doi:10.15252/msb.20145664 [doi]
    Nouguerede, E., Berenguer, C., Garcia, S., Bennani, B., Delfino, C., Nanni, I., . . . Ouafik, L. (2013)., Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo., Cancer Medicine, 2(2), 196-207. doi:10.1002/cam4.51 [doi]
    Pratt, S. E., Durland-Busbice, S., Shepard, R. L., Donoho, G. P., Starling, J. J., Wickremsinhe, E. R., . . . Dantzig, A. H. (2013)., Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts., Molecular Cancer Therapeutics, 12(4), 481-490. doi:10.1158/1535-7163.MCT-12-0654 [doi]
    Rettig, I., Koeneke, E., Trippel, F., Mueller, W. C., Burhenne, J., Kopp-Schneider, A., . . . Oehme, I. (2015)., Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation., Cell Death & Disease, 6, e1657. doi:10.1038/cddis.2015.24 [doi]
    Tegeder, I., Grosch, S., Schmidtko, A., Haussler, A., Schmidt, H., Niederberger, E., . . . Geisslinger, G. (2003)., G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: Involvement of p53 phosphorylation., Cancer Research, 63(8), 1846-1852.
    Zinke, J., Schneider, F. T., Harter, P. N., Thom, S., Ziegler, N., Toftgard, R., . . . Liebner, S. (2015)., Beta-catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma., Molecular Cancer, 14, 17-015-0294-4. doi:10.1186/s12943-015-0294-4 [doi]
    Zopf, S., Ocker, M., Neureiter, D., Alinger, B., Gahr, S., Neurath, M. F., & Di Fazio, P. (2012)., Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines., BMC Cancer, 12, 386-2407-12-386. doi:10.1186/1471-2407-12-386 [doi]